INSP Inspire Medical Systems, Inc.
$71.30▲ +0.41%
Healthcare
Other
Volume 569.9K
Avg Volume (10D) 705.3K
Key Metrics & Fundamentals
Market Cap
$2.06B
P/E Ratio
15.7
Div Yield
0.00%
52W Range
38.91 - 147.03
% vs 50 MA
4.86%
% vs 200 MA
20.98%
RSI-14
54.5
MACD Histogram
-0.0100
Beta (1Y vs SPY)
0.99
Free Cash Flow
$14.07M
Gross Rev
$200.58M
Gross Profit
$171.46M
EBITDA
$4.08M
COGS
$29.12M
Operating Exp
$171.97M
Operating Income
-$514,000
EBIT
-$514,000
Pretax Income
$3.12M
Net Income
$314,000
EPS (Diluted)
0.01
Price & Volume History
Loading chart…
Recent News
3 healthcare stocks we keep off our radar
StockStory · Oct 26, 2026 2:22 PM ET
INSP Stock Gains 47.8% in Three Months: What's Driving the Rally?
Zacks · Oct 23, 2026 10:37 AM ET
Here's How Tempus AI Demonstrates Improving Operating Leverage
Zacks · Oct 19, 2026 9:00 AM ET
Truist Securities Adjusts Inspire Medical Systems PT to $78 From $62, Maintains Hold Rating
MT Newswires · Oct 14, 2026 8:20 AM ET
Myomo Names Mary-Katherine McClure as Chief Commercial Officer
MT Newswires · Oct 12, 2026 4:28 PM ET
Myomo Appoints Mary-Katherine McClure as Chief Commercial Officer
Business Wire · Oct 12, 2026 4:05 PM ET
3 Cash-Heavy Stocks We Steer Clear Of
StockStory · Oct 8, 2026 4:00 AM ET
Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls
The Fly · Oct 7, 2026 10:00 AM ET
Barclays Initiates Inspire Medical Systems at Underweight With $65 Price Target
MT Newswires · Oct 7, 2026 8:12 AM ET
1 Profitable Stock Worth Your Attention and 2 We Ignore
StockStory · Oct 6, 2026 6:08 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See INSP's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.